J. Shim

发表

Cigarette smoking and mortality risk in people with schizophrenia.

D. Kelly, R. McMahon, H. Wehring, 2011, Schizophrenia bulletin.

Cardiovascular disease in relation to weight in deceased persons with schizophrenia.

R. Conley, D. Kelly, R. McMahon, 2005, Comprehensive psychiatry.

Combined Effects of Itraconazole and CYP2D6*10 Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Haloperidol in Healthy Subjects

J. Shim, Ji-Young Park, Jae-Gook Shin, 2006, Journal of clinical psychopharmacology.

The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine.

J. Shim, Eun-Young Kim, Jae-Gook Shin, 2007, British journal of clinical pharmacology.

Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.

R. Conley, D. Kelly, J. Shim, 2005, The Journal of neuropsychiatry and clinical neurosciences.

The Effect of Suggestion on Unpleasant Dreams Induced by Ketamine Administration

J. Shim, S. Cheong, K. Lee, 2011, Anesthesia and analgesia.

Increased Bone Mineral Density after Abstinence in Male Patients with Alcohol Dependence

J. Shim, D. Jung, Sung-Jin Kim, 2018, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Cardiovascular Disease Mortality in Chronic Schizophrenia Patients Treated with Clozapine

R. Conley, D. Kelly, H. Wehring, 2013 .

Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death.

R. Conley, D. Kelly, S. Feldman, 2004, Journal of psychiatric research.

The Effect of a Short-Term Family Psychoeducation Program for Schizophrenia on Family Burden and Emotions Towards Patients.

J. Shim, Hyun-Jung Kim, Jung-min Kim, 2013 .

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

R. Conley, D. Kelly, J. Shim, 2007, The American journal of psychiatry.

Adjunctive Treatment with Aripiprazole for Risperidone-Induced Amenrrhea

J. Shim, B. Kong, D. Jung, 2011 .

Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.

D. Kelly, J. Shim, Y. You, 2008, Journal of clinical psychopharmacology.

The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia.

R. Conley, D. Kelly, J. Shim, 2005, Journal of clinical psychopharmacology.

Electroconvulsive Therapy for Patients with Treatment-Resistant Schizophrenia Patients : A Retrospective Study

J. Shim, B. Kong, D. Jung, 2012 .

Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study

J. Shim, D. Jung, Sung-Jin Kim, 2018, Schizophrenia Research.

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)

F. Dickerson, D. Kelly, H. Wehring, 2013, BMC Psychiatry.

Rim1α and Neurexin3 Regulate Synaptosomal Dopamine Release

J. Shim, D. Seog, B. Kong, 2009 .

Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population

J. Shim, Jae-Gook Shin, I. Song, 2007, Drug Metabolism and Disposition.

Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters (hOCTs) in a Korean Population

J. Shim, Jae-Gook Shin, I. Song, 2007 .

The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia

J. Shim, B. Kong, D. Jung, 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

D. Kelly, J. Shim, Saejeong Lee, 2012, Neuropsychopharmacology.

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

J. Shim, Y. Ahn, S. Chang, 2013, Current medical research and opinion.

Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial

J. Shim, B. Kong, D. Jung, 2016, Schizophrenia Research.

The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia.

J. Shim, D. Jung, Sung-Jin Kim, 2019, Asian journal of psychiatry.

The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity

J. Shim, Jung-min Kim, D. Jung, 2017, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

The Korean Version of the Schizophrenia Cognition Rating Scale: Reliability and Validity

J. Shim, D. Jung, Sung-Jin Kim, 2017, Psychiatry investigation.

Differences in cognitive function and daily living skills between early- and late-stage schizophrenia

J. Shim, B. Kong, D. Jung, 2015, International journal of psychiatry in clinical practice.

Usefulness of the University of California San Diego Performance-Based Skills Assessment for the evaluation of cognitive function and activities of daily living function in patients with cognitive impairment

J. Shim, D. Jung, Sung-Jin Kim, 2019, Aging & mental health.

D. Kelly, H. Wehring, S. Feldman, 2009, Schizophrenia Research.

Cortisol response to buspirone in extended abstinent alcoholics.

R. Conley, D. Kelly, J. Shim, 2004, Alcohol and alcoholism.

The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders

D. Kelly, S. Feldman, J. Shim, 2011, Osteoporosis International.

Tolerability, Safety and Effectiveness of Paliperidone ER in Patients with Schizophrenia : A 24-Week Interim Analysis of the 48-Week Open-Label, Prospective, Switch Study